pharma · Retinitis Pigmentosa · Dry Eye Disease · KPRX
KIORA PHARMACEUTICALS
KIORA PHARMACEUTICALS INC
KIORA PHARMACEUTICALS clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Encinitas, USA
- Founded
- 2013
- Employees
- 18
- Programs
- 5
- Drugs
- 4
- Patents
- 4
KIORA PHARMACEUTICALS projects
5 ClinicalTrials.gov programs sponsored by KIORA PHARMACEUTICALS.
KIORA PHARMACEUTICALS has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
100 μg KIO-301
KIORA PHARMACEUTICALS INC
Retinitis Pigmentosa
1 trial -
KIO-101
KIORA PHARMACEUTICALS INC
Dry Eye Disease
1 trial -
KIO-104
KIORA PHARMACEUTICALS INC
Macular Edema
1 trial -
KIO-301
KIORA PHARMACEUTICALS INC
Retinitis Pigmentosa
1 trial -
OBG PED-001
KIORA PHARMACEUTICALS INC
Persistent Corneal Epithelial Defect
1 trial
Frequently asked questions
How many clinical projects does KIORA PHARMACEUTICALS have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.